ABSTRACT.
INTRODUCTION
One of the characteristic of solid tumors is the occurrence of regions with low oxygen tension as a result of uncontrolled cell growth and disordered angiogenesis, to which oxygen delivery can be restored through angiogenesis inhibition (1, 2) . This phenomenon contributes to a complicated microenvironment, where both continuous and cycling hypoxia are able to significantly affect tumor behavior, and are associated with poor prognosis due in part to a more aggressive tumor phenotype, resistance to chemotherapy and radiation, and increased genetic instability (3) . Therefore, targeting of hypoxia is considered a promising approach to augment the efficacy of cancer treatment (4, 5) .
Hypoxia induces multiple signaling pathways, resulting in activation of major transcription factors, including hypoxia-induced factors (HIFs), NF-κB, p53 and AP-1 (6, 7), which in turn regulate cellular responses to the lack of oxygen, such as metabolic adaptations, angiogenesis, cell death and autophagy, among others.
Autophagy is a catabolic process, involving "packing" of various cytoplasmic components into doublemembrane vehicles (autophagosomes), followed by their fusion with lysosomes and formation of autolysosomes, where degradation of the autophagic cargo takes place (8) . It was first extensively studied as an adaptive response to starvation, but later was acknowledged as a key process in maintenance of cellular homeostasis, damage responses and progression of various diseases, including cancer (9) . There is ample evidence for both oncosuppressive and tumor-supportive roles of autophagy, depending on cellular and tissue context (9) , which makes targeting autophagy a 6 MATERIALS AND METHODS.
Cells and reagents.
The HT 29 human adenocarcinoma cell line was purchased from ATCC (Manassas, VA). Immediately after receiving cells were thawed, propagated and frozen in multiple aliquots. For experiments, cells were used within 2 months or resuscitation. HT29-derived cell lines stably expressing empty vector (HTLX), dominant negative constructs for JNK1 (HTJ1.3) or JNK2 (HTJ2.2) were described in (21) . Cells were grown in DMEM medium supplemented with 10% FBS and antibiotic-antimycotic reagent (Invitrogen, Carlsbad, CA). Cultures were maintained in a humidified incubator at 37°C in 5%CO 2 -95% air. Chemical inhibitor for JNK (SP600125) was purchased from Biomol (Plymouth Meeting, PA), CC-401 was from ChemScene (Monmouth Junction, NJ). Chloroquine diphosphate and puromycin were from Sigma-Aldrich (St. Louis, MO), and oxaliplatin -from LKT Labs (St. Paul, MN). Acridine orange (AO) was purchased from Sigma, Apoptosis and Necrosis Quantification Kit was from Biotium (Hayward, CA).
Viral constructs and infections.
For stable delivery of shRNA against JNK1 and JNK2 into HT29-derived cell lines, we constructed retroviral vectors as described in Supplemental Figure S1 .
After transfection into Phoenix-Ampho packaging cell line viruses were collected, purified, aliquoted and stored at -80 o C. For infections, cells plated into 6 well plates were incubated with retroviruses in the presence of polybrene (8 μg/ml, Chemicon, Temecula, CA), and 48 hours later selective media containing 1 μg/ml of puromycin was added. Puromycin-resistant cells were pooled, evaluated for JNK1/JNK2 levels and used in further experiments.
For Bcl-X L knock-down, ready-to-use lentiviral particles (control and shRNA-encoding) were purchased from Santa Cruz (sc-77361-V), and used according to manufacturer's recommendations.
Since in pooled cultures knock-down of the target protein was incomplete, individual monoclonal sublines were isolated, assessed for Bcl-X L expression and used in further experiments. Hypoxic treatment. Exposure of cells to acute hypoxia was achieved by incubation in an anaerobic chamber (Forma Scientific, Inc., Marietta, OH) filled with gas mixture consisting of 5% CO 2 , 9% H 2 and 86% N 2 . Oxygen content (0.1-0.5%) was monitored by PROOX 110 oxygen sensor (BioSpherix, Redfield, NY). Cells were plated in 100 mm glass Petri dishes to a density of 2 x 10 6 cells per dish and subjected to hypoxia within 36 hours. The cells were harvested at various time points for further experiments.
Protein extract preparation. Total protein extracts were prepared as follows: after hypoxia, cells were washed twice with PBS and lyzed inside the chamber in cell lysis buffer (Cell Signaling Technology, Beverly, MA), supplemented with complete protease inhibitor cocktail (Roche) and 1mM PMSF (Sigma). The contents of scraped dishes were transferred into microcentrifuge tubes, taken out of hypoxia chamber and placed in a shaker for 30 min at 4 o C. Lysates were then centrifuged for 10 min at 10,000 rpm (4 o C) and the protein concentration of cleared extracts was measured using the Bio-8 immunoprecipitated overnight with goat antibodies (Santa Cruz, 20 μl) using ExactoCruz system (Santa Cruz Biotechnology) according to manufacturer's recommendations. Immunoprecipitates were lysed in 60 μl of 2x gel loading buffer, and subjected to electrophoresis (15 μl per lane) followed by Western blot analysis, using rabbit primary antibodies from Cell Signaling Technology.
Cytotoxicity assays and calculation of combination indices. For assessment of cytotoxicity, cells were plated in 96-well plates (2000 cells per well), and 24 hours later various amounts of oxaliplatin and chloroquine alone or in combination were added, immediately before hypoxic exposure for 24 hours, followed by cultivation in normal condition for additional 48 hours. Cytotoxicity was measured using a standard MTT assay. Combination indices (CI) were calculated based on ChouTalalay methods using CompuSinq software (as in 21), CI=1 indicates additivity, CI<1 indicates synergism, CI>1 indicates antagonism.
Transmission electron microscopy (TEM). For TEM quantitation of autophagosomes, HT29
cells were subjected to hypoxia and/or oxaliplatin (IC 50 dose) with or without 10 μM of SP600125.
Cell pellets were collected, fixed in 2.5% glutaraldehyde/2% formaldehyde with 0.1 M sodium cacodylate and stored at 4°C until embedding. Embedded samples were processed for TEM as described earlier (22). Images were examined with a JEOL-1010 electron microscope (JOEL) at 80 kV. For quantitation of cells using electron microscopy, high-powered micrographs (x12, 000-20,000) of 25 single cells from multiple distinct low-powered fields in each sample were obtained. Cells with more than three to four double-membrane vesicles were scored as positive for autophagosomes.
Fluorescent staining procedures.
To assess autophagy and apoptosis induction we employed fluorescent microscopy: i) autophagy induction (as LC3II puncta formation) was monitored in HT29 cells infected with GFP-LC3-encoding retrovirus (Addgene plasmid # 22405, pBABEpuro GFP-LC3 from Dr. Jayanta Debnath was used to generate retrovirus), ii) apoptotic cells were identified using Colony-forming assays. For clonogenic assays, cells were plated in 6-well plates at a density of 300 cells per well; after 24 hours oxaliplatin was added at specified concentrations immediately prior to transfer of the plates to the hypoxia chamber. After 24 hours of hypoxia, plates were returned to normal conditions for 48 hours, and, following the addition of fresh media, cultivated for 10-14 days; colonies were then fixed in 75% ethanol, stained with Coomassie Blue (Sigma) and counted manually. All experiments were performed at least two times in duplicate.
Caspase assays. For evaluation of caspases' activation, colorimetric assay kits for Caspase 8, Caspase 9 and Caspase 3 were used (Enzo Life Sciences, Farmingdale, NY). Cells were subjected to hypoxia with or without oxaliplatin (5 μM) for 24 hours, and caspase activation assays were performed according to manufacturer's recommendation. Results were quantified using a plate reader at 405nm, and presented as fold increase in caspase activity compared to untreated control in normal conditions. Statistical analysis. Data were analyzed with unpaired Student's test: P < 0.05 was accepted as a statistically significant difference compared with corresponding control. In figures: *, P < 0.05; **, P<0.01; ***, P<0.001.
RESULTS.

Pharmacological inhibition of JNK diminishes hypoxia-and oxaliplatin-induced autophagy in
HT29 colon adenocarcinoma cells. Earlier we examined the development of autophagy in hypoxiaand oxaliplatin-treated HT29 colon cancer cells, and demonstrated its induction by both treatments through fluorescent (GFP-LC3 puncta) and electron microscopic (EM) ultra-structural analyses (22).
To assess JNK involvement in autophagy induction, we treated HT29 cells with the JNK inhibitor SP600125 (10 μM), under hypoxia or with oxaliplatin (1xIC 50 dose) for 24 hours , followed by EM analysis. Our data demonstrate that both oxaliplatin-and hypoxia-induced formation of autophagosomes were reduced by SP600125, which confirms that JNK pathway is involved in the early steps of vacuolar formation during autophagy ( Figure 1A Table S1 ). We then continued with our studies in HT29-derived panel and observed increased sensitivity to CQ under hypoxia in all cell lines, with highest ratio of sensitization in HTJ1.3 and lowest in HTJ2.2 cells (Table   on November Figure 4B ). When hypoxia was followed by reoxygenation for additional 24 hours, we could still detect differential activation of autophagy, but apoptosis was activated equivalently in all three cell lines, suggesting that the severity of the stress could not be counteracted by autophagy in HTLX and HTJ2.2 cells (Supplemental Figure   S5 ). Finally, caspase activation assays demonstrated activation of intrinsic apoptotic pathway in HTJ1.3 cells (Figure 4C) , especially under hypoxia, whereas in HTLX and HTJ2.2 cell lines it was much less pronounced. These data is in accord with our previous findings, pointing to low level of apoptotic cell death in hypoxic HT29 treated with oxaliplatin (24), as compared to necrosis.
Bcl-X knock-down enhances apoptosis in HT29 cell without affecting induction of autophagy.
Since for intrinsic apoptosis the interactions between Bcl2-family members are crucial in setting cell In our cells both endogenous JNK1 and dominant negative JNK1 are present, resulting in competitive inhibition of signaling to c-Jun, which creates more complex environment. Since JNK1 was shown to be most effective activating kinase of the E3 ligase Itch, which is responsible for c-Jun ubiquitination and degradation (33), it is plausible to assume that JNK1 inhibition in HT29 cells could lead to increase in c-Jun levels. And although this phenomenon could be investigated further, we did not pursue it in this study, since it does not seem to affect autophagy inhibition in HTJ1.3 cells, as judged by multiple autophagy markers.
Autophagy induction, as a cellular response to stress, is dependent on genetic background. Thus, certain features of HT29 cells able to affect this process should be mentioned. It was shown that in multiple cell lines hypoxia-induced autophagy is mediated through the HIF-1 transcriptional target BH3-only protein BNIP3, which can displace Bcl2 from Beclin1, prompting autophagy activation (34, 35) . However, in colon cancer cell lines, including HT29, expression of BNIP3 is extremely low, due to epigenetic silencing of the promoter (36) . On the other hand, we have shown earlier high constitutive activity of ERK pathway in HT29 cells, both in normal conditions and upon hypoxia or (20, 37) , which could enhance autophagy (38) and underlie low apoptotic cell death in our model when treated with oxaliplatin, as compared to necrosis (24). Deregulation of intrinsic apoptosis could also be a consequence of the p53 mutation in HT29, since majority of BCL2-family members are p53 transcriptional targets (39) . When Benard et al (40) study, but are planning to do so after expansion of our model to a panel of colon cancer cell lines representative of human disease.
The complexity of cellular responses to stress, including hypoxia and DNA-damaging drugs, is staggering. Engagement of the same signaling pathways and molecular mechanisms with differing outcomes underlies the terminology often used when discussing the topic: double-edged sword, balance, switch, crosstalk. Crosstalks between autophagy, apoptosis, necrosis and necroptosis were described for various models (11), leading to the search for approaches to exploit these phenomena in targeted treatment of cancer (47) . Inhibitors of autophagy are currently tested in multiple clinical trials (48) , and combination of hydroxychloroquine with a standard chemotherapy was shown to be beneficial for the treatment of solid tumors (49, 50) . In our studies inhibiting autophagy with CQ (22) or JNK activity (through pan-JNK pharmacological inhibition or molecular JNK1 down-regulation 
